A new ringing, buzzing or hissing sound can be unsettling—particularly when it begins soon after starting a medicine or changing a dose. It is understandable to wonder whether the medication is responsible and whether you should stop taking it.
Important: Some medicines can trigger tinnitus, make existing tinnitus more noticeable, or affect hearing and balance. However, do not stop or change a prescribed medicine without speaking with the clinician who prescribed it. The medical reason for the treatment—and the risks of stopping suddenly—must be considered alongside the ear symptoms.
The relationship between medications and tinnitus is not always straightforward. A medicine may be genuinely toxic to the inner ear, tinnitus may be listed as an uncommon adverse effect, or the timing may be coincidental. A careful medication history and hearing assessment can help separate these possibilities.
Can medications really cause tinnitus?
Yes, some medications are associated with tinnitus. The term ototoxicity describes damage or disruption to the structures involved in hearing or balance caused by a medicine or chemical. Possible symptoms include tinnitus, hearing loss, dizziness, imbalance or difficulty seeing clearly while moving.
Not every medicine that lists tinnitus as a possible side effect is necessarily damaging the inner ear. Adverse-effect lists may include symptoms reported during clinical trials or after a medicine reaches the market, and they do not always establish that the medicine caused the symptom. This distinction matters because people can develop tinnitus for many other reasons, including hearing loss, noise exposure, earwax, middle-ear problems, jaw or neck factors, illness and stress.
The practical question is therefore not simply, “Is tinnitus written on the information sheet?” It is, “Does the timing, dose, hearing pattern and wider clinical picture suggest that this medicine may be contributing?”
Which medicines are most clearly associated with tinnitus or ototoxicity?
The level of evidence and the type of risk vary considerably between medication groups. Risk may depend on the dose, duration, method of administration, kidney function, age, genetics, previous hearing status, noise exposure and whether more than one potentially ototoxic medicine is being used.
High-dose salicylates and some anti-inflammatory medicines
Salicylates, including aspirin, are a well-known example of dose-related tinnitus. The association is most evident at higher doses. Tinnitus related to salicylates is often temporary and may settle after the dose is medically adjusted or the medicine is discontinued, but this decision belongs with the prescriber.
Some non-steroidal anti-inflammatory drugs (NSAIDs) also list tinnitus or hearing changes as possible adverse effects. This does not mean that everyone taking an anti-inflammatory is at risk, nor that a low-dose medicine should be stopped because tinnitus has appeared.
Aminoglycoside antibiotics
Aminoglycosides such as gentamicin, tobramycin, amikacin and streptomycin are used for particular serious infections. They can affect hearing and/or balance, and changes can sometimes be permanent. Risk is influenced by the total exposure, blood levels, kidney function, individual susceptibility and other medicines being used at the same time.
When these antibiotics are medically necessary, the objective is not to create fear around treatment. It is to identify hearing or balance changes as early as possible and keep the treating team informed.
Platinum-based chemotherapy
Cisplatin and, to a lesser extent, carboplatin are important cancer treatments with recognised potential to affect the inner ear. Tinnitus may occur with high-frequency hearing loss, and the change can be permanent. Baseline testing before treatment and monitoring during and after treatment can provide valuable information for the oncology team and help plan early hearing support if needed.
Loop diuretics
Loop diuretics such as furosemide are used for conditions involving fluid retention, heart function or kidney disease. Hearing changes and tinnitus are more often associated with high doses, rapid intravenous administration, impaired kidney function or use alongside another ototoxic medicine. Effects may be temporary, although every situation should be reviewed individually.
Quinine and related medicines
Quinine can produce a cluster of symptoms that includes tinnitus and hearing disturbance, particularly at higher exposure. Medicines used for malaria or other specific conditions should only be reviewed or altered by the treating clinician.
Antidepressants and other medicines
Tinnitus is reported with a wide range of other medications, including some antidepressants. This area requires particular care. Tinnitus can emerge after starting a medicine, after a dose change or during withdrawal; it can also fluctuate with the anxiety, sleep disturbance or health condition for which the medicine was prescribed.
A temporal association is useful information, but it is not proof. Antidepressants and many other medicines should not be stopped abruptly. A GP, psychiatrist or pharmacist can assess whether gradual adjustment, an alternative medicine or continued treatment is the safest option.
Why timing matters—but does not prove the cause
If tinnitus begins after a new prescription, it is helpful to record the sequence clearly. Note when the medicine started, when the tinnitus appeared, whether the dose changed, whether the sound is in one or both ears, and whether there is new hearing loss, dizziness or imbalance.
Also consider what else was happening at the time. A person may have started medication during an infection, a period of poor sleep, increased stress or a medical event that can itself affect tinnitus. New tinnitus may also coincide with loud-noise exposure or a change in hearing that has not yet been recognised.
This is why searching for a medicine on an online list rarely gives a complete answer. The pattern needs to be interpreted in context.
What should I do if I think my medication is affecting my tinnitus?
- Do not stop prescribed medication suddenly. Contact the prescriber or pharmacist and explain what has changed.
- Prepare a complete medication list. Include prescription medicines, pharmacy products, pain relief, supplements and the doses you take.
- Record the timeline. Note starts, stops, dose changes and the onset or change in tinnitus.
- Describe associated symptoms. Mention muffled hearing, difficulty understanding speech, sound sensitivity, dizziness, imbalance or ear pressure.
- Arrange a hearing assessment. An audiogram can identify whether tinnitus is accompanied by a measurable hearing change and provide a baseline for future comparison.
If a medically essential treatment is potentially ototoxic, the answer is not automatically to discontinue it. The treating doctor may need to balance the benefits of the medicine against the risk to hearing, consider dose or treatment alternatives where medically appropriate, and decide how monitoring should occur.
How can an audiologist help?
An audiologist does not prescribe or withdraw medication, but can provide objective information to support the medical decision. Depending on the situation, assessment may include:
- examination of the ear canals and eardrums
- conventional hearing thresholds
- extended high-frequency testing when appropriate
- speech understanding measures
- otoacoustic emissions in selected cases
- assessment of tinnitus characteristics and its effect on sleep, concentration and wellbeing
- comparison with any previous hearing results.
The audiologist can document the findings and, with your consent, communicate with your GP, oncologist or other specialist. Where medication cannot be changed, early identification also allows hearing and tinnitus support to begin sooner.
When does tinnitus need prompt medical attention?
Seek prompt medical assessment if tinnitus occurs with a sudden reduction in hearing, particularly in one ear. Sudden sensorineural hearing loss is time-sensitive and should not be assumed to be wax or a medication side effect.
Medical review is also important for new pulsatile tinnitus that follows the heartbeat, persistent one-sided tinnitus, significant vertigo, neurological symptoms, ear discharge or severe ear pain. The appropriate pathway depends on the complete symptom picture.
What if the medicine cannot be changed?
Sometimes the medication is essential and there is no safer substitute. That does not mean the person must simply tolerate intrusive tinnitus without support.
Management can address the factors keeping tinnitus prominent. This may include treatment of an associated hearing loss, therapeutic sound, sleep strategies, education about the auditory system and counselling approaches that reduce the threat response attached to the sound. Properly fitted hearing aids can be helpful when hearing loss is present because they restore access to environmental sound and reduce listening effort.
A balanced medication review is better than a blacklist
Long internet lists can make almost every medicine look dangerous. They rarely explain how strong the association is, whether the effect is dose-related, whether it is usually temporary, or why the medicine was prescribed.
A more useful approach is to combine the medication timeline with hearing results and the person’s broader medical history. At Ability Hearing & Balance, our tinnitus audiologist provides comprehensive assessment and individual management planning, and can liaise with the treating medical team where a medication contribution is suspected.
Read more about our tinnitus assessment and treatment options in Tasmania, or contact our team on 1300 327 776 to discuss the most appropriate appointment.
Sources and further reading
- Healthdirect Australia: Tinnitus
- American Speech-Language-Hearing Association: Ototoxic Medications
- Drug-Induced Ototoxicity: A Comprehensive Review and Reference Guide
- NICE guideline: Tinnitus—assessment and management
This article provides general information and does not replace advice from your doctor, pharmacist or treating specialist.
